Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 136Unknown 40Recruiting 34Terminated 28Active not recruiting 20Withdrawn 10Not yet recruiting 10Enrolling by invitation 4Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 39Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Colonic Neoplasms 13Esophageal Neoplasms 10Liver Neoplasms 9Rectal Neoplasms 8Esophageal Squamous Cell Carcinoma 8Cholangiocarcinoma 8Breast Neoplasms 8Barrett Esophagus 8Carcinoma, Non-Small-Cell Lung 6Neoplasms 5Postoperative Complications 4Liver Cirrhosis 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Diabetes Mellitus 4Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Lymphatic Metastasis 3Lung Neoplasms 3Fibrosis 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Anastomotic Leak 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Interventions

130-nm albumin-bound paclitaxel 2camrelizumab 1anlotinib 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Gallbladder Neoplasms × Gastrointestinal × Clear all
NCT07310069 2025-12-30

TRANSFORM-GBC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT06963060 2025-05-08

GALENT-BT

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

The First Affiliated Hospital of Zhengzhou University

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06671418 2024-11-04

TESLA RCT

Erasmus Medical Center

Phase 3 Enrolling by invitation
148 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡